A recent report published by Infinium Global Research on
needle-free diabetes care market provides an in-depth analysis of segments and
sub-segments in the global as well as regional needle-free diabetes care
market. The study also highlights the impact of drivers, restraints, and macro
indicators on the global and regional needle-free diabetes care market over the
short term as well as long term. The report is a comprehensive presentation of
trends, forecast and dollar values of the global needle-free diabetes care market.
According to the report, the global needle-free diabetes care market is
projected to grow at a CAGR of 14.40% over the forecast period of 2019-2025.
Needle-free diabetes care refers to the measurement of blood
glucose level with the help of biosensor and administration of insulin into the
human body without the pricking or removal of the blood. Diabetes is a
metabolic disorder in which an imbalance of blood glucose level occurs due to
the inadequate production of insulin in the body. Low level of blood glucose
can cause Symptoms like hyperglycaemic conditions, excessive excretion of
urine, hunger, thirst, weight loss, fatigue, and impaired vision. A traditional
way to test blood sugar level is usually by pricking their finger with a
lancet. This is a painful and uncomfortable process which may lead to less
frequent testing and results in improper control of blood sugar level.
Needle-free devices like transdermal biosensor, subcutaneous implants, and
devices with the combination of ultrasonic, electromagnetic and thermal waves
provide an easy way to measure blood glucose level and help into proper
administration of insulin in the human body.
A growing number of diabetic patients globally are boosting
the demand for diabetic care products. Also, the prevalence of diabetes is rising more rapidly in middle and
low-income countries are contributing to the rising demand for diabetic care
products. Moreover painful traditional methods and discomfort associated with
the detection of blood glucose level and administer insulin has become a major
driver for the demand of needle-free diabetic care products. On the other hand,
the high cost associated with the devices and technical illiteracy can restrain
the needle-free diabetes care market. However, the production of cost-effective
devices with extensive R and D and approval for newer products from regulatory
bodies can provide a good opportunity to needle-free diabetes care market.
Geographically global needle-free diabetes care market
categorized into North America, Europe, Asia Pacific and the Rest of the World.
North America expected to dominate the region in terms of revenue share. A rise
in research and development activities, increasing healthcare expenditure and
increasing awareness regarding diabetes management are some factors boosting the
growth of the market in this region. Asia-pacific anticipated growing with a
high CAGR in the forecast period. A tremendous rise in diabetic patients and
increasing adoption for advanced diabetic therapy will make the region dominant
in the near future. Europe is another growing region and expected to grow with
a consistent rate in the forecast period.
The report on the global needle-free diabetes care market covers
segments such as device type, and end-user. On the basis of device type, the
sub-markets include insulin patches, jet injectors, insulin pens, insulin
pumps, and insulin infuser. On the basis of end-user, the sub-markets include
diagnostic centres, hospitals and clinics, and consumer.
The report provides profiles of the companies in the market
such as Antares Pharma, Inc., European Pharma Group BV, Injex Pharma AG,
Pharmajet, Inc., Bioject Medical Technologies Inc., The 3M Company, Echo Therapeutics Inc.,
MannKind Corporation, Akra Dermojet, Medical International Technology, Inc.,
and Other companies.
The report provides deep insights into the demand forecasts,
market trends, and micro and macro indicators. In addition, this report
provides insights into the factors that are driving and restraining the growth
in this market. Moreover, The IGR-Growth Matrix analysis given in the report
brings an insight into the investment areas that existing or new market players
can consider. The report provides insights into the market using analytical
tools such as Porter's five forces analysis and DRO analysis of needle-free
diabetes care market. Moreover, the study highlights current market trends and
provides forecast from 2019-2025. We also have highlighted future trends in the
market that will affect the demand during the forecast period. Moreover, the
competitive analysis given in each regional market brings an insight into the
market share of the leading players.
Please Choose One of them.